FDA issued a Warning Letter to OriGen Biomedical, Inc. on 12/20/2018 as a result of this inspection.
483 OriGen Biomedical Jul 2018

483 OriGen Biomedical Jul 2018

Iris Macinnes FDA$119.00 - Available Now

FDA investigators audited the OriGen Biomedical - Austin, TX, United States facility and issued inspectional observations (via FDA 483) on 05 Jul 2018.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 05 Jul 2018
  • Location: Austin, United States
  • FEI: 1000160256
Add To Cart